These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 14434476)

  • 1. Biologic studies on the development of DON resistance in a mast-cell neoplasm of the mouse.
    POTTER M
    J Natl Cancer Inst; 1959 Jul; 23():163-81. PubMed ID: 14434476
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologic studies on the development of DON resistance in a mast-cell neoplasm of the mouse.
    POTTER M
    J Natl Cancer Inst; 1959 Jul; 23(1):163-81. PubMed ID: 13673276
    [No Abstract]   [Full Text] [Related]  

  • 3. The sulfomucopolysaccharides from a mast cell tumor of the mouse.
    GREEN JP; ROBERTS M; DAY M
    Biochem Pharmacol; 1963 Jul; 12():609-20. PubMed ID: 13950085
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of a plasma-cell neoplasm of the mouse. I. Characterization of neoplasm 70429, including its sensitivity to various antimetabolites with the rapid development of resistance to azaserine, DON, and N-methylformamide.
    POTTER M; LAW LW
    J Natl Cancer Inst; 1957 Mar; 18(3):413-41. PubMed ID: 13406561
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical and morphologic heterogeneity in a transplantable mast-cell neoplasm.
    MENGEL CE; TRIER JS
    J Natl Cancer Inst; 1961 Dec; 27():1341-59. PubMed ID: 14472640
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical and morphologic changes in a mast-cell neoplasm during treatment with cyclophosphamide.
    MENGEL CE; KELLY MG
    Cancer Res; 1961 Dec; 21():1545-50. PubMed ID: 14472639
    [No Abstract]   [Full Text] [Related]  

  • 7. Uridine diphosphoglucose dehydrogenase of mast cell tumours.
    HAMBRAEUS L; RODEN L; BOSTROM H
    Acta Soc Med Ups; 1959; 64():247-54. PubMed ID: 14399210
    [No Abstract]   [Full Text] [Related]  

  • 8. Deletion of Ptpn1 induces myeloproliferative neoplasm.
    Jobe F; Patel B; Kuzmanovic T; Makishima H; Yang Y; Przychodzen B; Hutchison RE; Bence KK; Maciejewski JP; Mohi G
    Leukemia; 2017 May; 31(5):1229-1234. PubMed ID: 28111468
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of Notch disruption on myeloid development.
    Francis OL; Chaudhry KK; Lamprecht T; Klco JM
    Blood Cancer J; 2017 Aug; 7(8):e598. PubMed ID: 28841212
    [No Abstract]   [Full Text] [Related]  

  • 10. 6-Diazo-5-oxo-L-norleucine, a new tumor-inhibitory substance. I. Biologic studies.
    COFFEY GL; EHRLICH J; FISHER MW; HILLEGAS AB; KOHBERGER DL; MACHAMER HE; RIGHTSEL WA; ROEGNER FR
    Antibiot Chemother (Northfield); 1956 Aug; 6(8):487-97. PubMed ID: 24544086
    [No Abstract]   [Full Text] [Related]  

  • 11. Jak2V617F driven myeloproliferative neoplasm occurs independently of interleukin-3 receptor beta common signaling.
    Vu T; Austin R; Kuhn CP; Bruedigam C; Song A; Guignes S; Jacquelin S; Ramshaw HS; Hill GR; Lopez AF; Lane SW
    Haematologica; 2016 Mar; 101(3):e77-80. PubMed ID: 26589916
    [No Abstract]   [Full Text] [Related]  

  • 12. [Low-molecular-weight immunocorrectors of natural origin].
    Ivanitskaia LP; Oparina ON; Stekhanova TN; Navashin SM
    Antibiot Med Biotekhnol; 1985 Feb; 30(2):131-8. PubMed ID: 3890722
    [No Abstract]   [Full Text] [Related]  

  • 13. The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis.
    Anastasi J
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):693-708. PubMed ID: 19577165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INTERACTION OF LASER RADIATION WITH BIOLOGIC SYSTEMS. II. EXPERIMENTAL TUMORS.
    KLEIN E; FINE S; LAOR Y; SIMPSON L; AMBRUS J; RICHTER W; SMITH GK; AARONSON C
    Fed Proc; 1965; 24():SUPPL 14:143-9. PubMed ID: 14281225
    [No Abstract]   [Full Text] [Related]  

  • 15. Acquired factor V deficiency in myeloproliferative neoplasms: a Mayo Clinic series of 33 patients.
    Ashrani AA; Tefferi A; Pruthi RK; Pardanani A
    Br J Haematol; 2015 Dec; 171(5):875-9. PubMed ID: 25854415
    [No Abstract]   [Full Text] [Related]  

  • 16. Murine myeloproliferative virus in cell culture.
    Soule HD; Arnold WJ
    J Natl Cancer Inst; 1970 Aug; 45(2):253-62. PubMed ID: 4929378
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical myeloproliferative disorders in adults.
    Zachée P
    Transfus Apher Sci; 2011 Apr; 44(2):211-21. PubMed ID: 21402312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: How to Treat?
    Tomé A; Pragosa H; Caldas G; Lacerda A; Pereira F
    J Pediatr Hematol Oncol; 2017 May; 39(4):323. PubMed ID: 28267092
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention and management of thrombosis in myeloproliferative neoplasms.
    Sekhar M
    Clin Adv Hematol Oncol; 2017 Mar; 15(3):178-181. PubMed ID: 28398271
    [No Abstract]   [Full Text] [Related]  

  • 20. Morphologic and biologic changes in a mouse ascites tumor following induced infection with certain viruses.
    KOPROWSKA I; KOPROWSKI H
    Cancer Res; 1953 Sep; 13(9):651-60. PubMed ID: 13094672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.